Grants and Contributions:
Title:
COVID 19 - Feasibility Study to Manufacture a Vaccine
Agreement Number:
956502
Agreement Value:
$1,874,945.00
Agreement Date:
Sep 21, 2020 - Jun 30, 2021
Description:
Enhanced conceptual engineering design for the installation of vaccine manufacturing capacity at BioVectra's current sites.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Charlottetown, Prince Edward Island, CA C1E 2E6
Reference Number:
172-2020-2021-Q3-956502
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
101379949
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 110 days.
Amendment Date
Mar 23, 2021
Recipient's Legal Name:
BioVectra Inc.
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: